Recent studies have also shown that MYDGF is involved in multiple metabolic disorders, including glucose and lipid metabolism, non-alcoholic fatty liver disease (NAFLD), and bone metabolism (Table 2). Here, MYDGF is linked to metabolic dysfunction-associated steatotic liver disease.